Corteva (CTVA) Projected to Announce Quarterly Earnings on Wednesday

Corteva (NYSE:CTVA) is projected to release its Q3 2026 results after the market closes on Wednesday, November 11th. Analysts expect Corteva to announce earnings of $0.0181 per share and revenue of $1.77 billion for the quarter. Interested persons may review the information on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 12, 2026 at 9:00 AM ET.

Corteva Trading Up 1.8%

Corteva stock opened at $12.11 on Tuesday. Corteva has a 52 week low of $11.24 and a 52 week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The stock has a market capitalization of $8.08 billion, a P/E ratio of 3.23, a PEG ratio of 1.71 and a beta of 0.58. The stock has a 50-day simple moving average of $43.38 and a 200 day simple moving average of $70.80.

Corteva Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Tuesday, December 1st will be given a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This is a negative change from Corteva’s previous quarterly dividend of $0.18. This represents a $0.20 dividend on an annualized basis and a dividend yield of 1.7%. Corteva’s payout ratio is 47.68%.

Analyst Ratings Changes

Several brokerages have recently commented on CTVA. Oppenheimer set a $17.00 target price on Corteva in a research note on Monday, October 5th. Mizuho increased their price target on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. UBS Group cut their price target on Corteva to $15.00 and set a “neutral” rating for the company in a report on Monday, October 12th. Bank of America lifted their price objective on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Finally, JPMorgan Chase & Co. upgraded shares of Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 price objective on the stock in a report on Tuesday, October 6th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $60.59.

About Corteva

Corteva, Inc is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases.

Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Corteva became an independent, publicly traded company in 2019 following the separation of DowDuPont.